PT  - JOURNAL ARTICLE
AU  - Safrai, Myriam
AU  - Reubinoff, Benjamin
AU  - Ben-Meir, Assaf
TI  - BNT162b2 mRNA Covid-19 vaccine does not impair sperm parameters
AID  - 10.1101/2021.04.30.21255690
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.04.30.21255690
4099  - http://medrxiv.org/content/early/2021/05/03/2021.04.30.21255690.short
4100  - http://medrxiv.org/content/early/2021/05/03/2021.04.30.21255690.full
AB  - Mass vaccination using newly approved vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has begun globally. However, their effect on fertility have not yet been investigated. Previous studies demonstrate that SARS-CoV-2 infection may impair sperm parameters. In this study, we are the first to assess the effect of the BNT162b2 mRNA Covid-19 vaccine on sperm parameters. Our results demonstrate that the vaccine does not impair sperm parameters. Thus, we recommend that couples desiring to conceive should vaccinate, as vaccination does not affect sperm whereas SARS-CoV-2 infection does impair sperm.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this workAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the institutional review board, Hadassah Medical Center IRB (Permit 0092-21-HMO). All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available on request from the corresponding author, [MS].